PBR · NYSE
| FY2010 | FY2009 | FY2008 | FY2007 | |
|---|---|---|---|---|
| Total Revenue | $150.85B | $115.89B | $146.53B | $112.42B |
| Research & Development | $993.00M | $681.00M | $941.00M | $881.00M |
| Selling, General & Administrative | $8.98B | $7.02B | $7.43B | $6.25B |
| Operating Expenses | $95.89B | $70.00B | $92.96B | $67.28B |
| Operating Income | $24.16B | $21.87B | $25.29B | $20.45B |
| Interest Expense | $869.00M | — | — | — |
| Other Income / (Expense) | $1.67B | $192.00M | $1.70B | — |
| Income Before Taxes | $25.83B | $22.06B | $26.99B | $19.30B |
| Provision for Income Taxes | $6.36B | $5.24B | $9.26B | $5.89B |
| Net Income | $19.48B | $16.82B | $17.73B | $13.41B |
| Period | Consensus EPS | Low | High | Estimates | Revisions |
|---|---|---|---|---|---|
| Dec 2026 | $4.63 | $4.44 | $4.81 | 2 | ↑1 ↓0 |
| Dec 2027 | $3.53 | $3.16 | $3.88 | 4 | ↑1 ↓2 |
| Dec 2028 | $3.70 | $3.56 | $3.82 | 3 | ↑0 ↓1 |
| Dec 2029 | $3.18 | $3.18 | $3.18 | 1 | ↑0 ↓0 |